A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004
Clinical trial NCT04277910 · COMPLETED
Trial details
- NCT number
- NCT04277910
- Sponsor
- Xi'an Biocare Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2021-04-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.